Knowledge of antibody structure is now sufficient to allow investigation of problems of biological function relative to structural parameters. One such structure-function relationship that can be approached is the molecular basis for complement (C) activation by immunoglobulins. On the basis of structural studies it has been proposed that the homology regions of immunoglobulins are arranged in a series of compact domains, with each domain mediating a biological function (1). In line with this hypothesis it has been suggested that the C~,2 domain may play a role in C fixation by IgG (2, 3). In 1971 Augener et al. by use of active C1 (CT) fixation assay showed that the 7S subunit of IgM could bind CT (4). Plaut et al. subsequently demonstrated that the (Fc)stt and Fctt fragments of IgM were capable of fixing C (5). We have investigated the relative capacity of small molecular weight fragments of a human WaldenstrSm IgM protein (Dau) to bind the first component of C and are thus able to present evidence for the localization of this function to a 24 amino acid sequence.
Materials and Methods
Preparation of IgM and Its Subfragments. IgM was isolated from the plasma of a patient (Dau) with Waldenstr6m's macroglobulinemia as previously described (6) . (Fc)stt and FabtL fragments were prepared using trypsin digestion at 60°C (6) . After separation of (Fc)5# and Fabtt on Sephadex G-200 in 1% NH4HCOs, pH 8, the (Fc)stt was further purified on Bio-Gel A-15 (Bio-Rad Laboratories, Richmond, Calif.). Cyanogen bromide (CNBr) cleavage of (Fc)~tz and Fabu was performed as described by Zikan and Bennett (7) . Dau Fc~ is composed of four CNBr fragments (7), designated CNBr 5 through CNBr 8 ( Fig. 1) . After CNBr cleavage the smaller fragments, CNBr 6 and CNBr 8, were removed by gel filtration (7) . The disulfide bonds in the pentameric CNBr 5 plus 7 fragment were then gently cleaved (either by partial oxidative sulfitolysis [8] or using 0.01 M dithiothreitol followed by alkylation with iodoacetamide) and the sample was applied to a Sephadex G-150 column in 5 M guanidine-HC1 to obtain CNBr 5 dimers and monomers which were free of CNBr 7, as shown by polyacrylamide disc electrophoresis in sodium dodecyl sulfate.
In addition, 33,000 mol wt Fctt fragments were prepared by reducing Fcstt with 0,05 M cysteine. The limited tryptic cleavage method of Hester and Schrohenloher (9) was used to release from the Fct~ fragments a homogeneous 6,800 mol wt fragment. This fragment was designated the C H4 fragment, since a comparison of its amino acid composition and partial sequence as determined in the sequenceP with that published by Putnam et al. (10) for the IgM, Ou, revealed that it was composed of the Cu4 domain of the FctL minus two tryptic peptides in the center of the loop (residues 468-491 and 515-550 according to the numbering of Ou). Relative to Dau CNBr fragments, C ~4 consisted of the carboxy-terminal 22 residues of CNBr 5 and the first two residues of CNBr 6 disulfide bonded to 36 residues of CNBr 7. CT-Binding Assay. The C-fixing ability of Dau IgM and its fragments was tested by a modified C]-fixation assay (4). The buffer utilized throughout the assay was dextrose-gelatin-veronal buffer of relative salt concentration 0.065 containing optimum amounts of Ca ++ and Mg ÷÷ (11) . An amount of functionally pure human C] sufficient to yield 63% lysis was incubated with serial dilutions of the test fragments or with buffer as a control for 10 min at 30°C. EAC4 (sheep erythrocytes [E] sensitized with rabbit antibody [A] to E to which C components have been added) (1.5 × 108/ml) were then added and incubation was allowed to proceed for an additional 10 rain. The resulting EAC1,4 cells were washed twice to remove unbound CT, and resuspended in the same buffer. An excess of functionally pure C2 (11) was then added, followed by an excess of C3-9 (guinea pig C diluted 1:50 in 0.01 M EDTA buffer which supplies an excess of the late-acting components) and the degree of lysis determined spectrophotometrically at 412 me. Appropriate controls were included for each experiment (11) . The amount of C1 fixed by an individual sample was calculated by subtracting the observed z value [-In (1 -y), where y = percent hemolysis], where z represents the average number of C]" molecules per cell, from the buffer control z value (11) .
Results
A C T f i x a t i o n p l o t for D a u I g M a n d its CH4 f r a g m e n t is s h o w n in Fig. 2 . 50% of the a v a i l a b l e C]" was fixed b y 1.5 g g of i n t a c t I g M w h e r e a s 46 ~,g of t h e CH4 f r a g m e n t w e r e r e q u i r e d to fix a n e q u i v a l e n t a m o u n t of C]'. T h e a m o u n t s of t h e o t h e r f r a g m e n t s of I g M w h i c h were n e (6) . (CNBr 5)2 (7), and C.4 Fragment ]. 1 S Amount required to bind 50% of the available CT.
highest amount tested, did not bind CT. However, if the assay were run such that whole human serum was incubated with the fragment (i.e., CHs0 fixation assay), there was C consumption as indicated by a drop from 160 CHso U to 95 CHs0 U. This is in agreement with the data published by Plaut et al. (5) for the (Fc)stt of another human monoclonal IgM (Dis). As the latter assay measures total hemolytic activity (11), it might be that (Fc)su activates the late-acting C components and very little, if any, CT is actually fixed. Partial reduction of (Fc)su provided Fctt fragments which were effective in binding CT. Controls, consisting of Fab# and partially reduced Fabtt, did not bind CT even at high concentrations. The 40,000 mol wt dimer of CNBr 5, which contains the Ctt3 and a portion of the Ctt4 domain, was found to bind CT effectively (only 20 ttg being required). In contrast, the control CNBr digest of Fabtt was not capable of binding CT. Finally, 46 ttg of the 6,800 mol wt C H4 fragment were needed to bind 50% of the available C1. Sedimentation velocity analysis of this fragment in the analytical ultracentrifuge in the buffer used for the CT fixation assay failed to reveal observable aggregation. In view of this, it is remarkable that on a molar basis the 60 residue C ~4 fragment is one-sixth as efficient as the Fcu fragment.
Discussion
The only primary structure common to the two smallest CT-fixing fragments, CH4 and CNBr 5, is the 24 residues on the amino-terminal side of the disulfide loop making up the Ctt4 domain (residues 468-491 in IgM Ou [10] ). These data lead us to suggest that this portion of the Fctt is responsible for CT binding. However, the possibility that the CT-binding site in the intact molecule may also involve other regions of the Fct+ is not necessarily ruled out. In this regard it would be particularly interesting to test the CT-fixing ability of the Ctt3 domain when a method for isolating it is found. It should be noted that the 24 residue sequence common to CH4 and CNBr 5 has the highest degree of homology to human /~2-microglobulin of any in the terminal domain, having 8 out of 24 identities and a total of 14 out of 24 conservative replacements (see Putnam et al. [10] and Peterson et al. [12] for comparative sequences). The relevance of this is pointed out by the fact that Painter et al. (13) have shown that/~2-microglobulin fixes CT with high efficiency. On the other hand, a similar sequence comparison to the IgG domains (14) reveals that the 24 residues of CH4 have a higher degree of homology to C~3 than to the C~,2 domain which has been suggested to be responsible for C activation on the basis of data accumulated using the CHs0 assay (2, 3). Specifically, there are 11 out of 24 identities and 4 conservative replacements between these 24 residues of the C H4 fragment and the analogous 24 residues in C~3, compared to 6 out of 24 identities and 3 conservative replacements between these 24 residues in C H4 and C~,2. In view of this and of our data indicating CHso but not CT fixation by (Fc)5# it would be of interest to compare the CT-fixing ability of Ct+4 with that of C'r2 and C~r3.
Summary
An insight into the structural features of human IgM that are responsible for its capacity to bind the first component of complement (C) has been obtained by examining the ability of IgM subfragments to bind active C1 (C1). The smallest two fragments found to bind C]" were the major CNBr fragment of the Fc portion of IgM and the C H4 fragment of the carboxy-terminal domain. The smallest fragment which fixes C]" has a disaggregated mol wt of 6,800, consists of 60 residues, and contains no carbohydrate. Structural considerations and sequence overlaps suggest that the amino-terminal side of the CH4 domain (24 amino acid residues) might be responsible for fixing C]'.
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